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Highlights 
 Baicalein enhanced the osteogenic differentiation of hPDLCs. 
 The optimal dosage of baicalein was 10 μM. 
 DKK-1 significantly reversed the effects of baicalein on hPDLCs. 
 The effects are exerted by activating the Wnt/β-catenin signaling pathway. 
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ABSTRACT 
Objective: Periodontium regeneration is one of the most important processes for periodontitis 
therapy. Human periodontal ligament cells (hPDLCs) play a vital role in the repair and 
regeneration of periodontal tissues. Our study aimed to investigated the mechanisms underlying 
the promotion of hPLDCsosteogenic differentiation by baicalein. 
Design: hPDLCs were obtained from periodontal ligament (PDL) tissues by primary culture. The 
MTT assay was used to determine the growth curves of hPDLCs treated with different 
concentrations of baicalein (1.25, 2.5, 5, or 10 μM). Alkaline phosphatase (ALP) staining and 
Alizarin red S staining were performed to assess osteogenic differentiation of hPDLCs 
administered baicalein. Osteogenic differentiation-related gene and protein expression levels and 
Wnt/β-catenin pathway signal changes were assessed by qRT-PCR and Western blotting analysis. 
Results: The results showed that baicalein decreased the growth of hPDLCs slightly and increased 
ALP activity and calcium deposition in a dose-dependent manner. The expression of runt-related 
transcription factor 2 (RUNX2), bone morphogenetic protein 2 (BMP2), Osterix (OSX) and 
osteocalcin (OCN) were elevated after baicalein administration. Moreover, baicalein strongly 
activated the Wnt/β-catenin pathway and up-regulated the expression of β-catenin, lymphoid 
enhancer factor 1 (LEF1) and Cyclin D1. Dickkopf-related protein 1 (DKK-1) significantly 
reversed the effects of baicalein on hPDLCs. 
Conclusions: Our findings indicated that baicalein enhanced the osteogenic differentiation of 
hPDLCs via the activation of the Wnt/β-catenin signaling pathway, which may represent a 
potential candidate for periodontitis therapy. 
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1. Introduction 
Periodontitis is regarded as the second most common dental disease worldwide 
(Schulze-Spate et al., 2015). Periodontitis is a set of inflammatory diseases that affect 
the periodontium, including periodontal ligament (PDL), cementum, and alveolar 
bone. Periodontitis involves the progressive loss of the alveolar bone around the teeth, 
and if left untreated can lead to the loosening and subsequent loss of teeth (Nanci & 
Bosshardt, 2006). The ultimate goal of periodontal therapy is to control periodontal 
tissue inflammation and to produce predictable regeneration of the part of the 
periodontium that has been destroyed as a result of the periodontal disease. However, 
non-surgical approach, surgical approach or adjunct antibiotic therapy may not be 
effective for certain patients, and additional bone regeneration therapy is inevitable to 
enable the reconstruction of the functional periodontium (Greenstein, 2000; Shimono 
et al., 2003; Tsalikis, Sakellari, Dagalis, Boura, & Konstantinidis, 2014). 
Unfortunately, there is no effective method for periodontitis treatment to date. Human 
periodontal ligament cells (hPDLCs) are the main functional cells in the PDL. 
hPDLCs differentiate into cementoblasts or osteoblasts that can generate mineralized 
tissues (Lekic, Rojas, Birek, Tenenbaum, & McCulloch, 2001). Therefore, hPDLCs 
play a vital role in the repair and regeneration of periodontal tissues (Isaka et al., 
2001). A strategy that can enhance the osteogenic differentiation of hPDLCs has been 
proposed as the treatment for periodontitis. 
Baicalein (5,6,7-trihydroxyflavone) is an active ingredient extracted from the 
traditional Chinese herb Scutellaria baicalensis Georgi, which has been reported to 
possess anti-inflammatory, anti-oxidant, anti-cancer and anti-type 2 diabetes 
properties and is widely used to treat various diseases (Lin, Shen, Lin, Yang, & Chen, 
2007; Li-Weber, 2009; Fan et al., 2013; Fu et al., 2014). Baicalein has been reported 
to stimulate osteoblastic MC3T3-E1 cell differentiation, inhibit osteoclast 
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differentiation and induce mature osteoclast apoptosis to promote bone metabolism 
(Kim, Lee, Kim, Min, & Kim, 2008; Kim et al., 2008). A recent study indicated that 
the active ingredients (baicalein and wogonin) from Scutellaria baicalensis Georgi 
influenced the promotion of proliferation and matrix calcification of hPDLCs (Liu et 
al., 2014). However, the effects of baicalein on the underlying signal transduction 
pathways have not been elucidated. 
The Wnt/β-catenin signaling pathway is perceived as a key for the optimization of 
the therapeutic approaches used to treat various skeletal diseases (Tang et al., 2014; 
Yorgan & Schinke, 2014). The Wnt/β-catenin signaling pathway plays an important 
role in the promotion of osteogenic differentiation and bone formation (Day, Guo, 
Garrett-Beal, & Yang, 2005; Rossini, Gatti, & Adami, 2013). Osteoanabolic agents 
that improve the function of the Wnt/β-catenin pathway may have a promising future 
for osteoporosis treatment (Bauman & Cardozo, 2015). Activating 
β-catenin-dependent transcription is the vital step in the activation of the canonical 
Wnt signaling pathway (Clevers & Nusse, 2012). Therefore, we hypothesize that the 
Wnt/β-catenin signaling pathway participates in this process and that baicalein affects 
the osteogenic differentiation of hPDLCs. 
In this study, we used baicalein to enhance and regulate the osteogenic 
differentiation potential of hPDLCs. Additionally, we investigated the role of 
baicalein in the regulation of the signaling pathways involved in the osteogenic 
differentiation of hPDLCs. 
 
2. Materials and Methods 
The study was approved by the Medical Ethics Committee of Wenzhou Medical 
University and the Hospital of Stomatology. The donors’ informed written consent 
was obtained before extraction. 
2.1 Primary culture and identification of hPDLCs 
hPDLCs were obtained from extracted healthy third molars from 6 donors aged 18 
to 30 years. The teeth were rinsed 3 times with sterile phosphate-buffered saline 
(PBS), and then the PDL was detached from the middle third of the root surface and 
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sliced into small pieces (1mm
3). PDL tissues were digested with type Ι collagenase 
(Sigma, USA) for 30 minutes at 37°C and then cultured in α-minimum essential 
medium (α-MEM, Gibco, USA) containing 10% fetal bovine serum (FBS, Millipore, 
USA), 2 mM L-glutamine, 100 U/mL of penicillin, and 100 mg/mL of streptomycin 
(Gibco, USA) at 37°C in a humidified atmosphere with 5% CO2. When the cells 
reached approximately 80% confluence, they were washed with PBS and detached 
with 0.25% trypsin plus 0.05% EDTA (Sigma, USA) for passaging. Cells at passages 
2-5 were used for the experiments. The medium was renewed every 3 days throughout 
the experiments. hPDLCs were identified through immunohistochemical staining for 
vimentin and cytokeratin(1:200, mouse, vimentin, BM0135, cytokeratin, BM0030, 
BosterBio, Wuhan, China) (Li, Han, Li, Wang, & Xu, 2013).  
 
2.2 Treatment of hPDLCs with baicalein 
Baicalein (≥90% purity, Sigma, USA) was dissolved in dimethylsulfoxide (DMSO, 
Sigma, USA) and filtered through a 0.22 μM strainer (Millipore, USA). Baicalein was 
serially diluted in α-MEM to final concentrations of 0, 1.25, 2.5, 5, and 10 μM. The 
concentration of DMSO did not exceed 0.1%, and medium containing 0.1% DMSO 
was used as a control (0 μM baicalein) in all experiments. The hPDLCs were seeded 
in 6-well plates at a density of 2×10
5
 cells/well and cultured until they reached 
60-70% confluence. Subsequently, the cells were separately incubated with 
baicalein-containing medium at the above-mentioned dilutions for 3, 7 or 11 days. 
 
2.3 Cell proliferation analysis 
The effects of baicalein on cell proliferation were assessed using the MTT (3-(4, 
5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay. The hPDLCs (5 × 
10
3
/well) were plated in a 96-well plate. After 12 h of incubation, the cells were 
treated with different concentrations of baicalein (0, 1.25, 2.5, 5, or 10 μM) for 1, 3, 5 
or 7 days. After treatment, 20 μL of 1 mg/ml MTT (Sigma, USA) solution was added 
to each well, and the plates were incubated in the dark for 4 h at 37 °C. The MTT was 
transformed by living cells (but not dead cells) into formazan crystals, which were 
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dissolved in 150 μL of DMSO by gentle shaking for 10 minutes. Finally, the optical 
density was measured at 490 nm, and the cell viability was normalized as the relative 
ratio of the absorbance to the absorbance of the control.   . 
 
2.4 Alkaline phosphatase (ALP) assay 
According to the results of pre-experiment, hPDLCs incubated with baicalein for 3 
days presented higher ALP expression compared to 7 and 11 days. So PDLCs were 
incubated with baicalein for 3 days and then induced to differentiate in osteogenic 
medium (10
-5
 mM dexamethasone, 50 μg/mL ascorbic acid, and 5 mM 
β-glycerophosphate) (Sigma, USA). After 7 days of osteogenic induction, the cells 
were washed 3 times with pre-cooled PBS and fixed with 4% paraformaldehyde 
(Beyotime, China) for 10 min at 4°C. Then, ALP staining was performed using the 
BCIP/NBT Alkaline Phosphatase Color Development kit according to the 
manufacturer's instructions (Beyotime, China). ALP activity was measured after the 
cells were incubated with baicalein for 3 days. The cells were washed 3 times with 
PBS and lysed with 1% Triton X-100 for 30 min. Then, the cells were harvested and 
measured with an ALP kit (Jiancheng Bioengineering, Nanjing, China) according to 
the manufacturer’s instructions. 
 
2.5 Alizarin red S staining 
According to the results of pre-experiment, hPDLCs incubated with baicalein for 
11 days formed more mineralized nodules. So the cells were treated with baicalein for 
11 days and then differentiated in osteogenic medium for 21 days. Alizarin red S 
staining was performed to evaluate calcium deposition in the mineralized nodules 
formed by the hPDLCs.  After 21 days of osteogenic induction, the cells were fixed 
with 4% paraformaldehyde and stained with l mg/mL Alizarin red S solution (pH 4.3) 
(Sigma, USA) for 30 min. Then, the cells were rinsed 3 times with deionized water. 
The images of stained cells were captured under a phase contrast microscope with a 
digital camera (Nikon, Japan). Calcium deposition was quantitatively determined by 
the cetylpyridinium chloride (CPC) method. The cells were destained with 
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cetylpyridinium chloride (Sigma, USA), and then the absorbance was measured at 
520 nm using a multifunctional microplate reader (TECAN, Switzerland). The 
absorbance was used to compare the concentration of Alizarin red S staining between 
groups. 
 
2.6 Quantitative Real-time PCR (qRT-PCR) assay 
Primers were designed and synthetized by Invitrogen, and the sequences of certain 
genes (including RUNX2, OCN, BMP2, OSX and Cyclin D1) were listed in Table 1. 
After the cells were treated with different concentrations of baicalein for 3, 7 and/or 
11 days, total RNA was isolated from each group with the TRIzol reagent (Invitrogen, 
USA). The purity and concentration of the total RNA were calculated through the 
absorbance at 260 and 280 nm. Then, 1 μg of RNA was reverse-transcribed into 
cDNA using the PrimeScript™ RT Reagent Kit (Takara, Japan) according to the 
manufacturer’s protocol. qRT-PCR was performed with the LightCycler 480 SYBR 
Green I Master (Roche, USA) on a LightCycler 480 system (Roche, USA); the 
program consisted of one cycle of 30 s at 95°C for activation, followed by 40 cycles 
of 5 s at 95°C for denaturing, 20 s at 60°C for annealing, and 20 s at 75°C for 
extension. To avoid primer dimer formation and false priming, melting curves were 
generated for all reactions. Each reaction was performed in triplicate with the same 
sample of cDNA, and the expression levels of the target genes were normalized to the 
expression of the internal control gene β-actin. The data were analyzed as fold 
changes according to the formula 2
-ΔΔCt
 . 
 
2.7 Western blotting analysis 
After 11 days of baicalein treatment for each group, the cells were lysed in ice-cold 
RIPA Lysis Buffer (Fude, China) containing 1mM PMSF and centrifuged at 10,000 x 
g for 20 min at 4°C. The protein concentration was quantified using the BCA assay kit 
(Fude, China). After the boiled proteins were separated by 8% SDS-PAGE, the 
proteins were transferred to a PVDF membrane. The membrane was blocked in 3% 
nonfat milk for 2 h and then incubated with primary antibodies (1:1000, rabbit, 
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β-catenin, #8480, LEF1, #2230, Cyclin D1, #2978, β-actin, #4970, Cell Signaling 
Technology, Inc., Danvers, MA, USA) at 4°C overnight. After washing 3 times with 
TBST for 15 min, the membrane was incubated with horseradish 
peroxidase-conjugated secondary antibodies (1:10000, goat anti-rabbit, β-catenin,  
LEF1, Cyclin D1, β-actin, Cell Signaling Technology, Inc., Danvers, MA, USA) at 
room temperature for 2 h. The membrane was washed with TBST 3 times for 15 min 
and then photographed with the Bio-Rad ChemiDoc
TM
 XRS+ using the ECL 
enhanced chemiluminescence kit (Millipore, USA). The band intensities were 
determined using Bio-Rad ChemiDoc XRS+ Imaging System and Quantity One 
software. 
 
2.8 Statistical analysis 
Every experiment was repeated three times independently, and the cells may or 
may not come from the same donor. But we undoubtedly use the same donor’s cells 
among different groups in the same experiment. The experimental results were 
expressed as the mean ± standard deviation (SD), and the significance of differences 
within groups was analyzed by one-way ANOVA with the LSD test. All statistical 
analyses were executed with the SPSS 19.0 software, with P < 0.05 considered 
statistically significant.  
 
3. Results 
3.1 Morphology and identiﬁcation of PDL cells 
The cells in the primary culture grew radially around the PDL tissue after one week 
(Fig.1A), and the passaged cells were spindle-shaped (Fig.1B). The 
immunohistochemical staining revealed that the cells were positive for 
vimentin(Fig.1C) but negative for cytokeratin (Fig.1D). Based on the cell morphology 
and scratched position of the PDL, these cells could be identified as hPDLCs. 
 
3.2 Effect of baicalein on the proliferation of hPDLCs 
The effect of various concentrations (1.25-10 μM) of baicalein on the proliferation 
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of hPDLCs was evaluated on days 1, 3, 5 and 7 (Fig. 2A). On day 1, baicalein in the 
range of 1.25-10 μM slightly inhibited the cell growth rate. On days 3, 5 and 7, the 
number of hPDLCs was decreased in the presence of baicalein in a dose-dependent 
manner; however, the decrease was not significant. 
 
3.3 Effect of baicalein on the ALP activity of hPDLCs 
The effect of baicalein on the early osteogenic differentiation of hPDLCs was 
assessed by staining for ALP (Fig. 2B) and testing the ALP activity (Fig. 2C). 
hPDLCs administered baicalein presented higher ALP expression and activity levels 
in a dose-dependent manner. The ALP activity of hPDLCs treated with 10 μM 
baicalein (B10) was significantly increased (p < 0.05) and was higher than that in 
B1.25 group (p < 0.05). However, there was no significant difference in the ALP 
activity of hPDLCs following the addition of 1.25 μM baicalein compared to the 
control (P >0.05) 
 
3.4 Effect of baicalein on calcium deposition 
The effect of baicalein on the late osteogenic differentiation of hPDLCs was 
evaluated by the formation of mineralized nodules (Fig. 2D) and calcium deposition 
(Fig. 2E). After 21 days of osteogenic differentiation, red mineralized nodules were 
visualized by Alizarin red S staining. The stain color grew deeper and thicker with the 
increasing concentration of baicalein, indicating that the amount of accumulated 
mineral matrix deposition was increased. We also quantified the calcium content 
using a destaining method. Compared to the control group, Alizarin red S deposition 
was remarkably increased in the presence of baicalein in a dose-dependent manner (p 
< 0.05). Notably, cells treated with 10 μM baicalein (B10) produced more calcium 
deposition than the cells in the 1.25, 2.5, and 5 μM baicalein groups (B1.25, B2.5, and 
B5) (p < 0.05). 
 
3.5 Effect of baicalein on the expression of osteogenic markers 
qRT-PCR was used to detect the expression of several osteogenic marker genes, 
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including runt-related transcription factor 2 (RUNX2) (Fig.3A), bone morphogenetic 
protein 2 (BMP2) (Fig.3B), Osterix (OSX) (Fig.3C) and osteocalcin (OCN) (Fig.3D), 
following administration of baicalein to the hPDLCs for 3, 7 and 11 days. RUNX2 
mRNA expression was increased in hPDLCs cultured with 10 μM baicalein on days 3 
and 7 and was significantly upregulated by baicalein treatment on day 11. The 
RUNX2 mRNA expression in the B5 and B10 groups was 2-fold higher as that of the 
control on day 11 (p < 0.05). The BMP2 mRNA level in the B10 group was 
significantly increased compared to the control (p < 0.05); the mRNA expression level 
was approximately 8-fold that of the control on day 11 and was higher than the levels 
detected in the B1.25, B 2.5 and B5 groups (p < 0.05). After baicalein administration, 
OSX expression was reduced compared to the control in all groups with the exception 
of the B10 group on day 3; however, the OSX expression was dramatically elevated 
on days 7 and 11 (p < 0.05). Indeed, the expression level detected in the B10 group 
was almost 21-fold that of the control group (p < 0.05) and was much higher than the 
other baicalein-treated groups (p < 0.05). On day 3, only 10 μM baicalein slightly 
increased the expression of OCN (p < 0.05); however, the expression was obviously 
upregulated on days 7 and 11 (p < 0.05). Similarly, the expression of OCN was 
significantly increased in the B10 group compared to the B1.25, B2.5 and B5 groups 
(p < 0.05). Thus, baicalein elevated the expression of osteogenic markers, especially 
at the 10 μM dosage. 
 
3.6 Activation of Wnt/β-catenin signaling during baicalein-stimulated osteogenic 
differentiation 
The effect of baicalein on the Wnt signaling pathway in hPDLCs was studied on 
the 11th day. According to the Western blotting results, three Wnt pathway-related 
regulators (β-catenin, LEF1 and Cyclin D1) were up-regulated by the 5 μM and 10 
μM baicalein treatments, particularly 10μM (Fig.4A). The mRNA level of the Wnt 
pathway target gene Cyclin D1 was markedly regulated in the presence of 10 μM 
baicalein (p < 0.05) (Fig.4B). To confirm whether the canonical Wnt/β-catenin 
pathway was involved in the osteogenesis of hPDLCs, the Wnt inhibitor DKK-1 (100 
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ng/ml) was added to the 10 μM baicalein-treated hPDLCs and cultured for 11 days. 
We found that treatment of the cells with DKK-1 decreased the baicalein-stimulated 
protein expression of the Wnt pathway-related regulators β-catenin, LEF1 and Cyclin 
D1 (Fig.4C). Additionally, the mRNA expression of Cyclin D1 was reduced by 40% 
compared to the 10 μM baicalein-treated hPDLCs (p < 0.05) (Fig.4D). 
 
3.7 Suppression of Wnt/β-catenin signaling by DKK-1 suppressed osteogenic 
differentiation of hPDLCs 
We found that treatment of the hPDLCs with DKK-1 down-regulated the 10 μM 
baicalein-stimulated ALP activity (Fig.5A, B) and calcium deposition (Fig.5C, D) (p < 
0.05). Moreover, the positive role of baicalein in the mRNA expression of osteogenic 
markers (Fig.5E) including RUNX2, BMP2, OSX and OCN was significantly blocked 
(p < 0.05) in the presence of DKK-1. 
 
4. Discussion 
hPDLCs have been represented as a promising resource to support periodontal 
regeneration and repair (Wolf et al., 2013). However, the capacity for tissue 
regeneration of hPDLCs in a chronic inflammatory microenvironment can be 
interfered (Xia et al., 2016). Nokhbehsaim et al. (Nokhbehsaim et al., 2011) observed 
that EMD-stimulated matrix mineralization and COL1 synthesis by PDL cells were 
diminished under IL-1β-induced inflammatory conditions, resulting in effects on 
periodontal tissue regeneration. Given the vital role of hPDLCs in bone regeneration, 
it is possible that agents that can enhance the osteogenesis of hPDLCs may be of 
value in bone regeneration in periodontitis. Recently, some studies have reported that 
some varieties of flavonoid compounds (i.e., quercetin, naringin and 
6-hydroxyflavone) have been demonstrated to be potential therapeutic agents for the 
treatment of osteoporosis and other bone disorders by augmenting bone formation 
(Lai et al., 2014; Liu, Li, & Yang, 2014; Zhou & Lin, 2014). Scutellaria baicalensis 
Georgi (Chinese name Huang-qin) contains abundant flavonoids, such as baicalin, 
baicalein, and wogonin. These flavonoids were demonstrated to benefit the synthesis 
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of both collagen and total protein in gingival fibroblasts (Chung, Park, & Bae, 1995). 
Moreover, baicalin was reported to up-regulate the collagen I mRNA and total protein 
levels and inhibit the expression of MMP-1/TIMP-1 in PDLCs, which was suggested 
to might be effective in periodontitis (Cao, Li, & Zhu, 2010). Baicalin could protect 
against periodontal tissue damage in ligature-induced periodontitis in rats (Cai, Li, Du 
G, & Cao, 2008). However, no study has clearly investigated the effect of baicalein on 
the osteogenic differentiation of hPDLCs and its underlying signal mechanism. 
Accordingly, we assessed the effects of baicalein on the osteogenic differentiation of 
hPDLCs in primary cultures in vitro. In the present study, we showed that baicalein 
promoted the osteogenic differentiation of hPDLCs and the canonical Wnt/β-catenin 
signaling pathway facilitated the process. 
The MTT assay indicated that baicalein slightly inhibited the viability of hPDLCs, 
which was similar to the finding that baicalein slightly attenuated the growth rate of 
MC3T3-E1 cells(Kim, Lee, Kim, Min, & Kim, 2008). 
  ALP is a vital enzyme that appears during the early phase of osteoblast 
differentiation and can accelerate the mineralization of the bone matrix (Bellows, 
Aubin, & Heersche, 1991; Serigano et al., 2010). In the present study, ALP was 
treated as a marker of the early osteogenic differentiation of hPDLCs. The late stage 
of osteogenesis of hPDLCs subjected to baicalein treatment was represented by the 
expression of extracellular matrix mineralization and calcium deposition. In our study, 
we discovered that baical in administration augmented the ALP activity and calcium 
deposition of hPDLCs in a dose-dependent manner. Previous study demonstrated that 
ALP activity was increased in osteoblastic MC3T3-E1 cells treated with 10 μM 
baicalein (Kim, Lee, Kim, Min, & Kim, 2008). It also found that baicalein induced the 
calcium deposition of MC3T3-E1 cells in a dose-dependent manner, at concentrations 
ranging from 1.25 to 10 μM. 
  Several osteogenic marker genes were also evaluated to determine whether 
baicalein was effective during the process of osteogenic differentiation of hPDLCs. 
BMP2, a member of the TGF-β family, promotes osteoblast differentiation and 
maturation, participates in the development and reconstruction of bone and cartilage, 
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and accelerates the repair of bone defects (Tsuji et al., 2006; Lowery et al., 2011). 
RUNX2 is a specific transcription factor that can induce osteoprogenitors or 
preosteoblasts to differentiate into osteoblasts and then proceed to regulate the 
maturation of osteoblasts (Zhang et al., 2011; Watanabe et al., 2013). OSX plays an 
important role in the initial regulation of bone tissue formation and reconstruction 
(Sun, Wang, & Hao, 2008). OCN is the most abundant non-collagenous protei n in 
bone and is a biological indicator used to assess bone formation during the late 
differentiation stage. There is a possibility that OCN can help regulate bone matrix 
mineralization (Thomas, Baker, Eisman, & Gardiner, 2001; Komori, 2006). In this 
study, the PCR analysis indicated that baicalein promoted the transcription of BMP2, 
RUNX2, OCN and OSX. It should be noted that higher concentrations of baicalein (5 
or 10 μM) significantly enhanced the osteogenic differentiation of hPDLCs, especially 
in 10 μM, in a time-dependent manner. Interestingly, on day 3, the expressions of 
RUNX2, OCN and OSX were down-regulated after low concentrations of baicalein 
treatment. Zhou et al. (Zhou & Lin, 2014) found that low concentrations of quercetin 
also inhibited the transcription of these osteogenic markers on adipose-derived stem 
cells (ASCs) differentiation, which is similar to baicalein. Further studies are required 
to elucidate the possible mechanism of the inhibitory effects. 
  The effects of the Wnt signaling pathway on osteogenic differentiation and bone 
formation have been universally reported (Day, Guo, Garrett-Beal, & Yang, 2005; 
Rossini, Gatti, & Adami, 2013; Saidak et al., 2015). A previous study indicated that 
the activation of Wnt/β-catenin signaling was involved in the osteogenesis of human 
periodontal ligament fibroblasts (Heo, Lee, & Lee, 2010). Activation of canonical 
Wnt/β-catenin signaling reversed H2O2-induced decreases in the proliferation and 
differentiation of human periodontal ligament fibroblasts (Kook et al., 2015). Some 
studies have suggested that the Wnt/β-catenin signaling pathway is linked to 
osteogenesis via the activation of β-catenin and that an accumulation of activated 
β-catenin may be sufficient to activate LEF1 and ultimately up-regulate the 
expression of its target gene Cyclin D1(Shtutman et al., 1999; Rossini, Gatti, & 
Adami, 2013). In the present study, the levels of β-catenin, LEF1 and Cyclin D1 were 
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enhanced after baicalein administration, indicating that Wnt/β-catenin signaling was 
involved in the baicalein-enhanced osteogenesis of hPDLCs. 
The Wnt/β-catenin signaling is activated by extracellular Wnt proteins but aslo 
occurs in response to other mechanical strain and chemical (Heo & Lee, 2011; Ying et 
al., 2014). In order to further investigate whether baicalein promotes osteogenic 
differentiation via Wnt/β-catenin signaling pathway, the specific inhibitor of 
Wnt/β-catenin signaling, DKK-1, was applied. DKK1 inhibits the accumulation of 
stabilized β-catenin by competitively binding to the LRP5 receptor and thereby 
blocking the interaction between Wnt2, Frizzled and LRP5/6 and resulting in the 
block of the Wnt/β-catenin signaling pathway (Ai, Holmen, Van Hul W, Williams, & 
Warman, 2005). The inhibition of Wnt/β-catenin signaling by DKK-1 abolished the 
baicalin-induced osteogenic effects (Guo et al., 2011). In our study, DKK-1 reduced 
the levels of β-catenin and LEF1, which subsequently depressed the transactivation of 
the target gene Cyclin D1. We also found that hPDLCs treated with DKK-1 reversed 
the baicalein-stimulated ALP activity and formation of mineralization. These results 
are consistent with previous reports suggesting that the addition of DKK-1 decreased 
β-catenin accumulation, ALP activity and matrix mineralization in osteoblasts (Qiang, 
Barlogie, Rudikoff, & Shaughnessy Jr, 2008; Guo et al., 2011). RUNX2 can be 
promoted by the up-regulation of β-catenin due to Wnt signaling activation and 
contribute to osteoblast differentiation (Gaur et al., 2005; Hamidouche et al., 2008). 
OSX and OCN act as downstream genes of RUNX2 (Ducy, Zhang, Geoffroy, Ridall, 
& Karsenty, 1997; Nakashima et al., 2002). Moreover, OSX is not expressed in 
Runx2/Cbfa1-null mice (Nakashima et al., 2002). In our study, the positive role of 
baicalein on these osteogenic markers was partially blocked by the inhibition of the 
β-catenin/LEF-1 pathway. These findings revealed that baicalein up-regulated the 
expression of osteogenic markers through the activation of the β-catenin/LEF-1 
pathway. BMP2 is a family member of another critical pathway (the bone 
morphogenetic proteins, BMPs) that enhances osteogenic differentiation. A study 
showed that DKK-1 abrogated BMP2-mediated osteoblast differentiation (Qiang, 
Barlogie, Rudikoff, & Shaughnessy Jr, 2008). Interestingly, the ascendant trend in 
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BMP2 expression due to baicalein administration was reversed by the addition of 
DKK-1. The cross interaction between the Wnt/β-catenin and BMP2 signaling 
pathways for osteoblast differentiation is worth further study. 
Taken together, blocking β-catenin in hPDLCs mostly prevented the positive effect 
of baicalein on osteogenic differentiation. We have not evaluated how DKK1 blocks 
the effect of baicalein on the osteogenic differentiation of hPDLCs, but we believe 
that baicalein administration increases the expression of canonical Wnt proteins, 
which subsequently elevates the expression of osteogenic-related factors and results in 
the osteogenesis of hPDLCs. 
There are some limitations to this study. PDLCs are a group of mixed population, 
which have limited differentiation potential as it contains high proportion of 
terminally differentiated cells. However, Periodontal ligament stem cells (PDLSCs), a 
newly subpopulation of MSCs, had been isolated from PDL tissues and PDLCs and 
had exhibited stronger osteogenic differentiation potentials than PDLCs. PDLSCs 
may be the better candidate for the study of periodontal regeneration (Alvarez, Lee, 
Wang, & Hong, 2015). 
5. Conclusions 
In summary, the present study demonstrated that baicalein (one of main effective 
components of Scutellaria baicalensis Georgi) could promote the osteogenesis of 
hPDLCs via the activation of the Wnt/β-catenin signal transduction pathway. Based 
on the results of this study, baicalein-enhanced osteogenesis of hPDLCs might be an 
attractive and promising treatment strategy to enhance alveolar bone formation and 
reconstruction in periodontitis.   
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Table 1 Primer Sequences 
Gene Forward (5’-3’) Reverse(5’-3’) 
RUNX2 CCCGTGGCCTTCAAGGT CGTTACCCGCCATGACAGTA 
BMP2 TATTTGGATAAGAACCAGACATTG GAAAGAAGAACAACAAACCATCA 
OSX ACCTACCCATCTGACTTTGCTC CCACTATTTCCCACTGCCTTG 
OCN AGCAAAGGTGCAGCCTTTGT GCGCCTGGGTCTCTTCACT 
Cyclin D1 TGATGCTGGGCACTTCATCTG TCCAATCATCCCGAATGAGAGTC 
β-actin    TGGCACCCAGCACAATGAA CTAAGTCATAGTCCGCCTAGAAGCA 
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Figure Legends 
Fig.1 (A) Primary culture of hPDLCs on the 7th day (×100); (B) morphology of 
hPDLCs at Passage 1 (×100); immunohistochemical staining of hPDLCs: (C) positive 
staining for vimentin (×100); (D) negative staining for cytokeratin (×100). 
 
Fig.2 Effects of baicalein on the proliferation and osteogenic differentiation of 
hPDLCs. (A) the proliferation of hPDLCs was analyzed by MTT assay;  (B) ALP 
staining and (C) ALP activity of hPDLCs after baicalein treatment; (D) Alizar n red S 
staining and (E) calcium deposition of hPDLCs after baicalein treatment. B0, control; 
B1.25, 1.25 μM baicalein; B2.5, 2.5 μM baicalein; B5, 5 μM baicalein; B10, 10 μM 
baicalein; *: compared to control, p < 0.05; #: compared to 10 μM baicalein group 
(B10), p < 0.05. 
 
Fig.3 qRT-PCR analysis of baicalein-enhanced osteogenic differentiation of hPDLCs: 
the mRNA expressions of osteogenic-related genes (A) RUNX2, (B) BMP2, (C) OSX 
and (D) OCN. B0: control; B1.25, 1.25 μM baicalein; B2.5, 2.5 μM baicalein; B5, 5 
μM baicalein; B10, 10 μM baicalein; *: compared to control, p < 0.05; #: compared to 
10 μM baicalein group (B10), p < 0.05. 
 
Fig.4 qRT-PCR and Western blotting analysis of baicalein-enhanced Wnt/β-catenin 
signaling of hPDLCs: (A) the protein expressions of β-catenin, LEF1 and Cyclin D1; 
(B) the mRNA expression of Wnt pathway target gene Cyclin D1; B0: control; B5, 5 
μM baicalein; B10, 10 μM baicalein. (C) DKK-1 blocks the protein expressions of β–
catenin, LEF1 and Cyclin D1 and (D) the mRNA expression of the target gene Cyclin 
D1; Control; DKK-1, 100 ng/mL human recombinant DKK-1; B10, 10 μM baicalein; 
B10+DKK-1, 10 μM baicalein plus 100 ng/mL human recombinant DKK-1. *: 
compared to control, p < 0.05; #: compared to 10 μM baicalein group (B10), p < 0.05. 
 
Fig.5  DKK-1 partially blocked the positive effect of baicalein on the osteogenic 
differentiation of hPDLCs: (A) ALP staining and (B) ALP activity; (C) alizarin red S 
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staining and (D) calcium deposition assay; (E) qRT-PCR assay: the mRNA 
expressions of osteogenic-related genes RUNX2, BMP2, OSX and OCN. Control; 
DKK-1, 100 ng/mL human recombinant DKK-1; B10, 10 μM baicalein; B10+DKK-1, 
10 μM baicalein plus 100 ng/mL human recombinant DKK-1; *: compared to control, 
p < 0.05; #: compared to 10 μM baicalein group (B10), p < 0.05. 
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Figure5
